Drugs / Tyrosinase, MAGE-3, GnTV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00153569 | Mar 2003 → Sep 2005 | metastatic melanoma | Charite University, Berlin, Germany | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tyrosinase, MAGE-3, GnTV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00153569 ↗ |